Skip to main content

Docosanol topical Pregnancy and Breastfeeding Warnings

Brand names: Abreva

Medically reviewed by Drugs.com. Last updated on Dec 8, 2023.

Docosanol topical Pregnancy Warnings

The manufacturer makes no recommendation regarding use in pregnancy.

US FDA pregnancy category: Not formally assigned to a pregnancy category.

Animal studies have not been reported. There are no controlled data in human pregnancy.

See references

Docosanol topical Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. (2001) "Product Information. Abreva (docosanol topical)." SmithKline Beecham
  2. MedicinesComplete. Pharmaceutical Press (2011) Martindale: the Complete Drug Reference. http://www.medicinescomplete.com/mc/martindale/current/

References for breastfeeding information

  1. (2001) "Product Information. Abreva (docosanol topical)." SmithKline Beecham
  2. MedicinesComplete. Pharmaceutical Press (2011) Martindale: the Complete Drug Reference. http://www.medicinescomplete.com/mc/martindale/current/

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.